BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly mistakes. It just badly hurt those who had bought shares of Teva Pharmaceutical Industries TEVA,  because ...
Read more »

TRUMP’S ‘OBAMACARE LITE’ PRESENTS OPPORTUNITIES AND PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL

Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

This post was just published on ZYX Buy Change Alert. On February 1st we issued a call to take profits on MNTA.  Depending upon how you traded, your profits would have been 74%. We got out at the top.  ...
Read more »

MOMENTA PHARMACEUTICALS JUMPS ON COPAXONE RULING, TAKE PROFITS AND EXIT THE POSITION IF STILL HOLDING $MNTA $MYL $TEVA

This post was published on ZYX Buy Change Alert. MNTA has an average price of $11.31.  As of this writing it is trading at $19.05. The stock has jumped on a court invalidating TEVA patent on a MS ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

MYLAN BENEFITING FROM COPAXONE $MYL $TEVA

This post was just published on ZYX Buy Change Alert. MYL is benefiting from invalidation of TEVA patent on Copaxone, an MS drug.  The new buy zone is $32 to $35.57.  Recommended position size is 35% to 40%.  ...
Read more »

PLAN ON MYLAN: TEVA PHARMACEUTICAL, TAX LOSS SELLING AND TRUMP $MYL $TEVA

This post was just published on ZYX Buy Change Alert. TEVA MYL is a generic drug manufacturer.  The earlier decline in the stock was in sympathy with TEVA.  TEVA is the largest generic drug manufacturer in the world.  TEVA's ...
Read more »

SMART MONEY LIGHTLY STEPS INTO MYLAN $MYL $ENDP $IPXL $LCI $TARO $TEVA

This post was just published on ZYX Buy Change Alert. Algorithms at The Arora Report have been detecting smart money lightly stepping into MYL throughout the morning. MYL stock is up significantly more than others in the group taking ...
Read more »

UPDATE ON MYLAN $MYL $TEVA $LCI $IPXL $ENDP $TARO

This post was just published on ZYX Buy Change Alert. All generic drug manufacturers are falling on the news that U. S. prosecutors are starting an investigation on price collusion among generic drug manufacturers. Of note is that MYL ...
Read more »

SMART MONEY SELLS INTO MYLAN RISE FOR A GOOD REASON $MYL $FRX $ACT $TEVA

Since the Feb. 18 announcement that Actavis would acquire Forest Laboratories for about $25 billion, which caused Forest Laboratories stock to leap higher, Mylan stock has been moving up strongly in sympathy on speculation it, too, could ...
Read more »

CUBIST PHARMACEUTICALS (CBST) ACQUISITION TARGET

Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player.  Cubist has received upgrades from several brokers.  At present, cubist satisfies ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers